Lv5
1195 积分 2021-02-07 加入
How multispecific molecules are transforming pharmacotherapy
20天前
已完结
HT-6184 Inhibits the Formation of the NLRP3 Inflammasome in Human Monocytic THP-1 Cells
25天前
已关闭
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
26天前
已完结
Discovery of a Novel Potent and Orally Efficacious PROTAC Degrader of HPK1 for Tumor Immunotherapy
1个月前
已完结
NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D
1个月前
已完结
Overcoming E3 Ligase-Mediated Resistance: Development of Novel Hydrophobic Tagging-Based Degraders Targeting ALK Protein
1个月前
已完结
Small molecule interleukin 17A/A antagonists and antibodies blocking both IL17A/A & IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammation
1个月前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
1个月前
已完结
Discovery of a Novel EGFR PROTAC Degrader against C797S Resistance Mutation with Potent Antitumor Efficacy in NSCLC Treatment
1个月前
已完结
The changing landscape of medicinal chemistry optimization
1个月前
已完结
皖公网安备34019202002308
